Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Langenbeck's Archives of Surgery
Published in: Langenbeck's Archives of Surgery 5/2009

01-09-2009 | Current Concepts in Endocrine Surgery

Intraoperative adjuncts in surgery for primary hyperparathyroidism

Authors: Barney J. Harrison, Frederic Triponez

Published in: Langenbeck's Archives of Surgery | Issue 5/2009

Login to get access

Abstract

Purpose

This paper is a review of the evidence base to produce recommendations for the use of intraoperative parathyroid hormone (PTH), radioguided parathyroidectomy (RGP), methylene blue (MB), frozen section, and intraoperative neuromonitoring during surgery for primary hyperparathyroidism (PHPT).

Materials and methods

A Medline keyword search of English-language articles led to the production of a draft document, subsequently revised by committee, containing levels of evidence and the grading of recommendations as proposed by the Agency for Healthcare Research and Quality.

Results

Literature review provides the basis for clear recommendations on the use of intraoperative PTH at surgery for PHPT. There is little evidence to support the use of RGP, MB, routine frozen section, and intraoperative neuromonitoring.
Appendix
Available only for authorised users
Literature
1.
Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137(9):1055–1059PubMedCrossRef
2.
Sharma J, Milas M, Berber E, Mazzaglia P, Siperstein A, Weber CJ (2008) Value of intraoperative parathyroid hormone monitoring. Ann Surg Oncol 15(2):493–498PubMedCrossRef
3.
Miccoli P, Berti P, Materazzi G, Ambrosini CE, Fregoli L, Donatini G (2008) Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: a prospective randomized trial. Surg Endosc 22(2):398–400PubMedCrossRef
4.
Barczynski M, Cichon S, Konturek A, Cichon W (2006) Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 30(5):721–731PubMedCrossRef
5.
Baliski CR, Stewart JK, Anderson DW, Wiseman SM, Bugis SP (2005) Selective unilateral parathyroid exploration: an effective treatment for primary hyperparathyroidism. Am J Surg 189(5):596–600 discussion 600PubMedCrossRef
6.
Sidhu S, Neill AK, Russell CF (2003) Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg 27(3):339–342PubMedCrossRef
7.
Russell CF, Dolan SJ, Laird JD (2006) Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg 93(4):418–421PubMedCrossRef
8.
Udelsman R, Donovan PI (2004) Open minimally invasive parathyroid surgery. World J Surg 28(12):1224–1226PubMedCrossRef
9.
Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS (2004) Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 130(1):87–91PubMedCrossRef
10.
Carneiro-Pla DM, Solorzano CC, Irvin GL 3rd (2006) Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 202(5):715–722PubMedCrossRef
11.
Nilsen FS, Haug E, Heidemann M, Karlsen SJ (2006) Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study. Scand J Surg 95(1):28–32PubMed
12.
Gil-Cardenas A, Gamino R, Reza A, Pantoja JP, Herrera MF (2007) Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy? J Am Coll Surg 204(2):286–290PubMedCrossRef
13.
Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L (2006) Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision-making? J Am Coll Surg 203(1):1–6PubMedCrossRef
14.
Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr (2006) Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg 141(4):381–384 discussion 384PubMedCrossRef
15.
Mihai R, Palazzo FF, Gleeson FV, Sadler GP (2007) Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg 94(1):42–47PubMedCrossRef
16.
Pang T, Stalberg P, Sidhu S, Sywak M, Wilkinson M, Reeve TS, Delbridge L (2007) Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring. Br J Surg 94(3):315–319PubMedCrossRef
17.
Lew JI, Solorzano CC, Montano RE, Carneiro-Pla DM, Irvin GL 3rd (2008) Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery 144(2):299–306PubMedCrossRef
18.
Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B (2007) Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf) 66(6):878–885CrossRef
19.
Ito F, Sippel R, Lederman J, Chen H (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245(6):959–963PubMedCrossRef
20.
Irvin GL 3rd, Solorzano CC, Carneiro DM (2004) Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28(12):1287–1292PubMedCrossRef
21.
Richards ML, Thompson GB, Farley DR, Grant CS (2008) Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 196(6):937–942 discussion 942–933PubMedCrossRef
22.
Yen TW, Wang TS, Doffek KM, Krzywda EA, Wilson SD (2008) Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 144(4):611–619 discussion 619–621PubMedCrossRef
23.
Carter AB, Howanitz PJ (2003) Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 127(11):1424–1442PubMed
24.
Bieglmayer C, Prager G, Niederle B (2002) Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem 48(10):1731–1738PubMed
25.
Woodrum DT, Saunders BD, England BG, Burney RE, Doherty GM, Gauger PG (2004) The influence of sample site on intraoperative PTH monitoring during parathyroidectomy. Surgery 136(6):1169–1175PubMedCrossRef
26.
De Vos tot Nederveen Cappel R, Bouvy N, de Herder W, de Rijke Y, van Toor H, Bonjer J (2007) Novel criteria for parathyroid hormone levels in parathyroid hormone-guided parathyroid surgery. Arch Pathol Lab Med 131(12):1800–1804
27.
Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery 140(6):883–889 discussion 889–890PubMedCrossRef
28.
Agarwal G, Barakate MS, Robinson B, Wilkinson M, Barraclough B, Reeve TS, Delbridge LW (2001) Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost-effectiveness study. Surgery 130(6):963–970PubMedCrossRef
29.
Gauger PG, Mullan MH, Thompson NW, Doherty GM, Matz KA, England BG (2004) An alternative analysis of intraoperative parathyroid hormone data may improve the ability to detect multiglandular disease. Arch Surg 139(2):164–169PubMedCrossRef
30.
Karakousis GC, Han D, Kelz RR, Nemani D, Karamacharya J, Roses R, Gimotty PA, Fraker DL (2007) Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 142(6):845–850 discussion 850 and 841–842PubMedCrossRef
31.
Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B (2007) A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery 142(3):398–404PubMedCrossRef
32.
Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, Milas M (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248(3):420–428PubMed
33.
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134(6):973–979 discussion 979–981PubMedCrossRef
34.
35.
Rolighed L, Heickendorff L, Hessov I, Garne JP, Rodt SA, Christiansen P (2004) Primary hyperparathyroidism: intraoperative PTH-measurements. Scand J Surg 93(1):43–47PubMed
36.
Di Stasio E, Carrozza C, Pio Lombardi C, Raffaelli M, Traini E, Bellantone R, Zuppi C (2007) Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem 40(9–10):595–603PubMed
37.
Emmolo I, Corso HD, Borretta G, Visconti G, Piovesan A, Cesario F, Borghi F (2005) Unexpected results using rapid intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism. World J Surg 29(6):785–788PubMedCrossRef
38.
Phillips IJ, Kurzawinski TR, Honour JW (2005) Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery. Ann Clin Biochem 42(Pt 6):453–458PubMedCrossRef
39.
Mozzon M, Mortier PE, Jacob PM, Soudan B, Boersma AA, Proye CA (2004) Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine PTH measurement the morning after. Ann Surg 240(6):949–953 discussion 953–944PubMedCrossRef
40.
Lombardi CP, Raffaelli M, Traini E, Di Stasio E, Carrozza C, De Crea C, Zuppi C, Bellantone R (2008) Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch Surg 393(5):639–645PubMedCrossRef
41.
Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159PubMedCrossRef
42.
McGill J, Sturgeon C, Kaplan SP, Chiu B, Kaplan EL, Angelos P (2008) How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies. J Am Coll Surg 207(2):246–249PubMedCrossRef
43.
Gauger PG, Agarwal G, England BG, Delbridge LW, Matz KA, Wilkinson M, Robinson BG, Thompson NW (2001) Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery 130(6):1005–1010PubMedCrossRef
44.
Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG (2004) Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg 28(2):187–192PubMedCrossRef
45.
Carneiro DM, Irvin GL 3rd (2000) Late parathyroid function after successful parathyroidectomy guided by intraoperative hormone assay (QPTH) compared with the standard bilateral neck exploration. Surgery 128(6):925–929 discussion 935–926PubMedCrossRef
46.
Westerdahl J, Bergenfelz A (2006) Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation. Arch Surg 141(6):589–594PubMedCrossRef
47.
Norman J, Denham D (1998) Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery 124(6):1088–1092 discussion 1092–1083PubMedCrossRef
48.
Chen H, Mack E, Starling JR (2005) A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg 242(3):375–380 discussion 380–373PubMed
49.
Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, Pelizzo MR (2003) Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q J Nucl Med 47(2):129–138PubMed
50.
Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, Manca G, Casara D, Sotti G, Erba P, Volterrani D, Giuliano AE (2003) Preoperative localization and radioguided parathyroid surgery. J Nucl Med 44(9):1443–1458PubMed
51.
Inabnet WB 3rd, Kim CK, Haber RS, Lopchinsky RA (2002) Radioguidance is not necessary during parathyroidectomy. Arch Surg 137(8):967–970PubMedCrossRef
52.
Chen H, Mack E, Starling JR (2003) Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238(3):332–337 discussion 337–338PubMed
53.
Goldstein RE, Billheimer D, Martin WH, Richards K (2003) Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg 237(5):722–730 discussion 730–721PubMedCrossRef
54.
Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137(6):659–668 discussion 668–659PubMedCrossRef
55.
Schachter PP, Issa N, Shimonov M, Czerniak A, Lorberboym M (2004) Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg 139(4):433–437PubMedCrossRef
56.
Casara D, Rubello D, Pelizzo MR, Shapiro B (2001) Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 28(9):1351–1359PubMedCrossRef
57.
Burkey SH, Van Heerden JA, Farley DR, Thompson GB, Grant CS, Curlee KJ (2002) Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism? World J Surg 26(8):914–920PubMedCrossRef
58.
McGreal G, Winter DC, Sookhai S, Evoy D, Ryan M, O’Sullivan GC, Redmond HP (2001) Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol 8(10):856–860PubMedCrossRef
59.
Norman J, Chheda H (1997) Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 122(6):998–1003 discussion 1003–1004PubMedCrossRef
60.
Farley DR (2004) Technetium-99m 2-methoxyisobutyl isonitrile-scintigraphy: preoperative and intraoperative guidance for primary hyperparathyroidism. World J Surg 28(12):1207–1211PubMedCrossRef
61.
Bozkurt MF, Ugur O, Hamaloglu E, Sayek I, Gulec SA (2003) Optimization of the gamma probe-guided parathyroidectomy. Am Surg 69(8):720–725PubMed
62.
Friedman M, Gurpinar B, Schalch P, Joseph NJ (2007) Guidelines for radioguided parathyroid surgery. Arch Otolaryngol Head Neck Surg 133(12):1235–1239PubMedCrossRef
63.
Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139(11):1175–1179PubMedCrossRef
64.
Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW (2006) Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg 72(9):785–789 discussion 790PubMed
65.
Murphy C, Norman J (1999) The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 126(6):1023–1028 discussion 1028–1029PubMedCrossRef
66.
Hanif F, Coffey JC, Romics L Jr, O’Sullivan K, Aftab F, Redmond HP (2006) Rapid intraoperative parathyroid hormone assay—more than just a comfort measure. World J Surg 30(2):156–161PubMedCrossRef
67.
Rubello D, Piotto A, Casara D, Muzzio PC, Shapiro B, Pelizzo MR (2003) Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures. Eur J Endocrinol 149(1):7–15PubMedCrossRef
68.
Norman J, Politz D (2008) Measuring individual parathyroid gland hormone production in real-time during radioguided parathyroidectomy. Experience in over 8,000 operations. Minerva Endocrinol 33(3):147–157PubMed
69.
Rubello D, Mariani G, Pelizzo MR (2007) Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients: refinement of preoperative imaging and intraoperative procedure. Nuklearmedizin 46(3):85–92PubMed
70.
Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH (2002) Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 87(3):1024–1029PubMedCrossRef
71.
Fahy BN, Bold RJ, Beckett L, Schneider PD (2002) Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg 137(8):917–922 discussion 922–913PubMedCrossRef
72.
Geelhoed GW, Silverberg SG (1984) Intraoperative imprints for the identification of parathyroid tissue. Surgery 96(6):1124–1131PubMed
73.
Shidham VB, Asma Z, Rao RN, Chavan A, Machhi J, Almagro U, Komorowski RA (2002) Intraoperative cytology increases the diagnostic accuracy of frozen sections for the confirmation of various tissues in the parathyroid region. Am J Clin Pathol 118(6):895–902PubMedCrossRef
74.
Hosking SW, Jones H, du Boulay CE, McGinn FP (1993) Surgery for parathyroid adenoma and hyperplasia: relationship of histology to outcome. Head Neck 15(1):24–28PubMedCrossRef
75.
Saxe AW, Baier R, Tesluk H, Toreson W (1985) The role of the pathologist in the surgical treatment of hyperparathyroidism. Surg Gynecol Obstet 161(2):101–105PubMed
76.
Westra WH, Pritchett DD, Udelsman R (1998) Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol 22(5):538–544PubMedCrossRef
77.
Anton RC, Wheeler TM (2005) Frozen section of thyroid and parathyroid specimens. Arch Pathol Lab Med 129(12):1575–1584PubMed
78.
Baloch ZW, LiVolsi VA (2002) Intraoperative assessment of thyroid and parathyroid lesions. Semin Diagn Pathol 19(4):219–226PubMed
79.
Boggs JE, Irvin GL 3rd, Carneiro DM, Molinari AS (1999) The evolution of parathyroidectomy failures. Surgery 126(6):998–1002 discussion 1002–1003PubMed
80.
Levin KE, Clark OH (1989) The reasons for failure in parathyroid operations. Arch Surg 124(8):911–914 discussion 914–915PubMed
81.
Robertson GS, Iqbal SJ, Bolia A, Bell PR, Veitch PS (1992) Intraoperative parathyroid hormone estimation: a valuable adjunct to parathyroid surgery. Ann R Coll Surg Engl 74(1):19–22PubMed
82.
Roslyn JJ, Mulder DG, Gordon HE (1981) Persistent and recurrent hyperparathyroidism. Am J Surg 142(1):21–25PubMedCrossRef
83.
Elliott DD, Monroe DP, Perrier ND (2006) Parathyroid histopathology: is it of any value today? J Am Coll Surg 203(5):758–765PubMedCrossRef
84.
Perrier ND, Ituarte P, Kikuchi S, Siperstein AE, Duh QY, Clark OH, Gielow R, Hamill T (2000) Intraoperative parathyroid aspiration and parathyroid hormone assay as an alternative to frozen section for tissue identification. World J Surg 24(11):1319–1322PubMedCrossRef
85.
Chan RK, Ibrahim SI, Pil P, Tanasijevic M, Moore FD (2005) Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates. Arch Surg 140(4):371–373PubMedCrossRef
86.
Lo CY, Chan WF, Leung P, Luk JM (2005) Applicability of tissue aspirate for quick parathyroid hormone assay to confirm parathyroid tissue identity during parathyroidectomy for primary hyperparathyroidism. Arch Surg 140(2):146–149 discussion 150PubMedCrossRef
87.
Conrad DN, Olson JE, Hartwig HM, Mack E, Chen H (2006) A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J Surg Res 133(1):38–41PubMedCrossRef
88.
Dewan AK, Kapadia SB, Hollenbeak CS, Stack BC Jr (2005) Is routine frozen section necessary for parathyroid surgery? Otolaryngol Head Neck Surg 133(6):857–862PubMedCrossRef
89.
Dudley NE (1971) Methylene blue for rapid identification of the parathyroids. Br Med J 3(5776):680–681PubMedCrossRef
90.
Bambach CP, Reeve TS (1978) Parathyroid identification by methylene blue infusion. Aust N Z J Surg 48(3):314–317PubMedCrossRef
91.
Devine RM, van Heerden JA, Grant CS, Muir JJ (1983) The role of methylene blue infusion in the management of persistent or recurrent hyperparathyroidism. Surgery 94(6):916–918PubMed
92.
Gordon DL, Airan MC, Thomas W, Seidman LH (1975) Parathyroid identification by methylene blue infusion. Br J Surg 62(9):747–749PubMedCrossRef
93.
Kuriloff DB, Sanborn KV (2004) Rapid intraoperative localization of parathyroid glands utilizing methylene blue infusion. Otolaryngol Head Neck Surg 131(5):616–622PubMedCrossRef
94.
Orloff LA (2001) Methylene blue and sestamibi: complementary tools for localizing parathyroids. Laryngoscope 111(11 Pt 1):1901–1904PubMedCrossRef
95.
Schell SR, Dudley NE (2003) Clinical outcomes and fiscal consequences of bilateral neck exploration for primary idiopathic hyperparathyroidism without preoperative radionuclide imaging or minimally invasive techniques. Surgery 133(1):32–39PubMedCrossRef
96.
Sherlock DJ, Holl-Allen RT (1984) Intravital methylene blue staining of parathyroid glands and tumours. Ann R Coll Surg Engl 66(6):396–398PubMed
97.
Sinha SN, Subramaniam P (1996) Initial parathyroid exploration: current trends in Australia. Aust N Z J Surg 66(5):279–281PubMedCrossRef
98.
Takei H, Iino Y, Endo K, Horiguchi J, Maemura M, Koibuchi Y, Horii Y, Yokoe T, Ishida T, Oyama T, Morishita Y (1999) The efficacy of technetium-99m-MIBI scan and intraoperative methylene blue staining for the localization of abnormal parathyroid glands. Surg Today 29(4):307–312PubMedCrossRef
99.
Traynor S, Adams JR, Andersen P, Everts E, Cohen J (1998) Appropriate timing and velocity of infusion for the selective staining of parathyroid glands by intravenous methylene blue. Am J Surg 176(1):15–17PubMedCrossRef
100.
Wheeler MH, Wade JS (1982) Intraoperative identification of parathyroid glands: appraisal of methylene blue staining. Am J Surg 143(6):713–716PubMedCrossRef
101.
Cox RJ, Moore DB, Wolfman EF Jr (1979) Localization of the parathyroid glands by intraoperative methylene blue staining. Surg Gynecol Obstet 148(5):769–770PubMed
102.
Gavilan J, Gavilan C, Tomas MD (1986) Methylene blue infusion for intraoperative identification of the parathyroid glands. Laryngoscope 96(12):1389–1390PubMed
103.
Derom AF, Wallaert PC, Janzing HM, Derom FE (1993) Intraoperative identification of parathyroid glands with methylene blue infusion. Am J Surg 165(3):380–382PubMedCrossRef
104.
Bland KI, Tidwell S, von Fraunhofer JA, Morris RR, McCoy MT, Wathen RL (1985) Intraoperative localization of parathyroid glands using methylthionine chloride/tetramethylthionine chloride in secondary hyperparathyroidism. Surg Gynecol Obstet 160(1):42–48PubMed
105.
Flynn MB, Bumpous JM, Schill K, McMasters KM (2000) Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 191(1):24–31PubMedCrossRef
106.
Grady JA, Bumpous JM, Fleming MM, Flynn MB, Turbiner E, Lentsch EJ, Ziegler CH (2006) Advantages of a targeted approach in minimally invasive radioguided parathyroidectomy surgery for primary hyperparathyroidism. Laryngoscope 116(3):431–435PubMedCrossRef
107.
Han N, Bumpous JM, Goldstein RE, Fleming MM, Flynn MB (2007) Intra-operative parathyroid identification using methylene blue in parathyroid surgery. Am Surg 73(8):820–823PubMed
108.
Martin RC 2nd, Greenwell D, Flynn MB (2000) Initial neck exploration for untreated hyperparathyroidism. Am Surg 66(3):269–272PubMed
109.
Robert J, Delay D, Buhler L, Garcia A, Spilipoulos A (1998) Methylene blue in surgery of primary hyperparathyroidism. Ann Endocrinol (Paris) 59(1):23–26
110.
Ahmed TS (2006) Methylene blue toxicity following infusion to localize parathyroid adenoma. J Laryngol Otol 120(8):708 author reply 708–709PubMed
111.
Bach KK, Lindsay FW, Berg LS, Howard RS (2004) Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesth Analg 99(5):1573–1574 table of contentsPubMedCrossRef
112.
Khan MA, North AP, Chadwick DR (2007) Prolonged postoperative altered mental status after methylene blue infusion during parathyroidectomy: a case report and review of the literature. Ann R Coll Surg Engl 89(2):W9–W11PubMedCrossRef
113.
Majithia A, Stearns MP (2006) Methylene blue toxicity following infusion to localize parathyroid adenoma. J Laryngol Otol 120(2):138–140PubMedCrossRef
114.
Mathew S, Linhartova L, Raghuraman G (2006) Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy. Anaesthesia 61(6):580–583PubMedCrossRef
115.
Patel AS, Singh-Ranger D, Lowery KA, Crinnion JN (2006) Adverse neurologic effect of methylene blue used during parathyroidectomy. Head Neck 28(6):567–568PubMedCrossRef
116.
Vutskits L, Briner A, Klauser P, Gascon E, Dayer AG, Kiss JZ, Muller D, Licker MJ, Morel DR (2008) Adverse effects of methylene blue on the central nervous system. Anesthesiology 108(4):684–692PubMedCrossRef
117.
Licker M, Diaper J, Robert J, Ellenberger C (2008) Effects of methylene blue on propofol requirement during anaesthesia induction and surgery. Anaesthesia 63(4):352–357PubMedCrossRef
118.
Kartha SS, Chacko CE, Bumpous JM, Fleming M, Lentsch EJ, Flynn MB (2006) Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg 135(5):765–768PubMedCrossRef
119.
Sweet G, Standiford SB (2007) Methylene-blue-associated encephalopathy. J Am Coll Surg 204(3):454–458PubMedCrossRef
120.
Martindale SJ, Stedeford JC (2003) Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia 58(10):1041–1042PubMedCrossRef
121.
Shanmugam G (2005) Vasoplegic syndrome—the role of methylene blue. Eur J Cardiothorac Surg 28(5):705–710PubMedCrossRef
122.
Masaki E, Kondo I (1999) Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats. Anesth Analg 89(2):484–489PubMedCrossRef
123.
Evgenov OV, Sveinbjornsson B, Bjertnaes LJ (2001) Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep. Acta Anaesthesiol Scand 45(10):1246–1254PubMedCrossRef
124.
Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P (2007) 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg 31(11):2075–2080PubMedCrossRef
125.
Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235(5):665–670 discussion 670–662PubMedCrossRef
126.
Bergenfelz A, Jansson S, Martensson H, Reihner E, Wallin G, Kristoffersson A, Lausen I (2007) Scandinavian Quality Register for Thyroid and Parathyroid Surgery: audit of surgery for primary hyperparathyroidism. Langenbecks Arch Surg 392(4):445–451PubMedCrossRef
127.
Barwell J, Lytle J, Page R, Wilkins D (1997) The NIM-2 nerve integrity monitor in thyroid and parathyroid surgery. Br J Surg 84(6):854PubMedCrossRef
128.
Brennan J, Moore EJ, Shuler KJ (2001) Prospective analysis of the efficacy of continuous intraoperative nerve monitoring during thyroidectomy, parathyroidectomy, and parotidectomy. Otolaryngol Head Neck Surg 124(5):537–543PubMedCrossRef
129.
Marcus B, Edwards B, Yoo S, Byrne A, Gupta A, Kandrevas J, Bradford C, Chepeha DB, Teknos TN (2003) Recurrent laryngeal nerve monitoring in thyroid and parathyroid surgery: the University of Michigan experience. Laryngoscope 113(2):356–361PubMedCrossRef
130.
Snyder SK, Hendricks JC (2005) Intraoperative neurophysiology testing of the recurrent laryngeal nerve: plaudits and pitfalls. Surgery 138(6):1183–1191 discussion 1191–1182PubMedCrossRef
131.
Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ, Kruse E, Grond S, Muhlig HP, Richter C, Voss J, Thomusch O, Lippert H, Gastinger I, Brauckhoff M, Gimm O (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136(6):1310–1322PubMedCrossRef
132.
Barczynski M, Konturek A, Cichon S (2009) Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 96(3):240–246PubMedCrossRef
133.
Hermann M, Alk G, Roka R, Glaser K, Freissmuth M (2002) Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: effect of nerve dissection and impact of individual surgeon in more than 27, 000 nerves at risk. Ann Surg 235(2):261–268PubMedCrossRef
134.
Jatzko GR, Lisborg PH, Muller MG, Wette VM (1994) Recurrent nerve palsy after thyroid operations—principal nerve identification and a literature review. Surgery 115(2):139–144PubMed
135.
Riddell VH (1956) Injury to recurrent laryngeal nerves during thyroidectomy; a comparison between the results of identification and non-identification in 1022 nerves exposed to risk. Lancet 271(6944):638–641PubMedCrossRef
136.
Randolph G, Urken M (2003) Surgical management of primary hyperparathyroidism. In: Randolph G (ed) Surgery of the thyroid and parathyroid glands. Saunders, Philadelphia, pp 507–528
Metadata
Title
Intraoperative adjuncts in surgery for primary hyperparathyroidism
Authors
Barney J. Harrison
Frederic Triponez
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 5/2009
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-009-0532-6

Other articles of this Issue 5/2009

Langenbeck's Archives of Surgery 5/2009 Go to the issue

Endocrine Surgery

Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy

Original Article

How to perform a thyroidectomy in an outpatient setting

Original Article

Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy—a feasibility study

Original Article

Intraoperative real-time 99mTc-sestamibi scintigraphy with miniature gamma camera allows minimally invasive parathyroidectomy without ioPTH determination in primary hyperparathyroidism

Current Concepts in Endocrine Surgery

Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery

Current concepts in Endocrine Surgery

Hyperparathyroidism–jaw tumor syndrome: a report of three large kindred